http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108658939-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2018-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108658939-B
titleOfInvention A kind of synthetic method of key intermediate of dabigatran etexilate mesylate
abstract The present invention relates to a kind of [2-[[(4-cyanophenyl)amino]-methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridine-2-yl)amino ] the synthetic method of ethyl propionate, reaction formula is as follows: It includes the following steps: 1) the compound SM01 reacts with the coupling reagent CDI in a toluene solution; 2) step 1) after the reaction is completed, the obtained reaction solution is cooled, and the toluene solution of SM02 is added to react; 3) after the reaction is completed, acetic acid is added , and continue to react to the end. Compared with the prior art, the synthetic method provided by the present invention uses a single solvent, does not need to replace the solvent in the middle of the reaction, is easy to operate, has few by-products, and has a high yield, with a yield of 93-96%, and is easy to obtain high-purity synthetic method. The product DB02, its HPLC content is above 99%. This method is suitable for industrial production.
priorityDate 2018-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015132794-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015124764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014049585-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426248706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21941165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135566083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453892555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511924

Total number of triples: 46.